AtriCure shareholder seeks damages after “false claims”
This article was originally published in Clinica
Executive Summary
Cardiac surgical ablation firm AtriCure is being sued by several of its shareholders over claims that it issued misleading statements regarding its involvement in improper promotion of its products to physicians and the filing of false claims for reimbursement.